AE Wealth Management LLC Takes Position in Align Technology, Inc. $ALGN

AE Wealth Management LLC bought a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 5,190 shares of the medical equipment provider’s stock, valued at approximately $650,000.

A number of other hedge funds have also recently bought and sold shares of ALGN. Steigerwald Gordon & Koch Inc. acquired a new stake in Align Technology in the 3rd quarter valued at about $26,000. Rothschild Investment LLC raised its holdings in shares of Align Technology by 140.3% in the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 87 shares in the last quarter. True Wealth Design LLC raised its holdings in shares of Align Technology by 7,650.0% in the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 153 shares in the last quarter. Quent Capital LLC acquired a new stake in Align Technology during the third quarter valued at approximately $30,000. Finally, TD Private Client Wealth LLC boosted its holdings in Align Technology by 135.6% during the third quarter. TD Private Client Wealth LLC now owns 238 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 137 shares in the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ALGN has been the topic of several research reports. Morgan Stanley upped their price target on Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Wall Street Zen upgraded Align Technology from a “hold” rating to a “buy” rating in a report on Saturday, January 3rd. Evercore ISI reduced their target price on Align Technology from $220.00 to $170.00 and set an “outperform” rating for the company in a report on Tuesday, November 25th. Wells Fargo & Company decreased their price target on Align Technology from $199.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Finally, HSBC boosted their price objective on Align Technology from $140.00 to $150.00 in a report on Friday, October 31st. Six equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $176.82.

Align Technology Trading Up 2.7%

Shares of NASDAQ:ALGN opened at $161.30 on Thursday. The firm has a market cap of $11.57 billion, a price-to-earnings ratio of 31.26, a P/E/G ratio of 1.76 and a beta of 1.84. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $232.20. The business has a fifty day simple moving average of $161.89 and a 200 day simple moving average of $148.59.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 EPS for the quarter, topping the consensus estimate of $2.99 by $0.30. The company had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.03 billion. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.44 earnings per share. On average, sell-side analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology News Roundup

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q4 results beat consensus — GAAP EPS of $3.29 vs. $2.99 expected and revenue of ~$1.048B vs. ~$1.03B expected, showing year-over-year improvement and better-than-forecast profitability. Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Management cited strong demand for dental products (Invisalign system and related digital solutions) as the driver of the beat, which supports revenue momentum going into the new quarter. Align Technology beats fourth-quarter results estimates on dental products demand
• Positive Sentiment: Full press release and reported metrics: total Q4 revenue +5.3% year-over-year and sequential growth; company provided supporting slide deck and call for more detail (useful for investors who want line-of-business and regional breakdowns). Align Technology Announces Fourth Quarter and Fiscal 2025 Financial Results
• Neutral Sentiment: Q1 guidance was reported roughly in line with analyst expectations — this tempers upside from the print (no major beat-and-raise) and means future stock moves will depend on execution and trends called out on the conference call. Align Technology beats fourth-quarter results estimates on dental products demand

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.